Case Study: Prolonged infectious SARS-CoV-2 shedding from an asymptomatic immunocompromised cancer patient.
Case Study: Prolonged infectious SARS-CoV-2 shedding from an asymptomatic immunocompromised cancer patient.This case study describes a female immunocompromised patient with chronic lymphocytic leukemia and acquired hypogammaglobulinemia who became persistently infected with SARS-CoV-2. Though asymptomatic throughout the course of infection, the patient demonstrated prolonged shedding of both infectious SARS-CoV-2 virus and RNA. This study demonstrates certain patients may remain infectious for prolonged periods of time and highlights the need for further studies to understand risk factors for prolonged infectious SARS-CoV-2 shedding.This case study describes a female immunocompromised patient with chronic lymphocytic leukemia and acquired hypogammaglobulinemia who became persistently infected with SARS-CoV-2. Though asymptomatic throughout the course of infection, the patient demonstrated prolonged shedding of both infectious SARS-CoV-2 virus and RNA. This study demonstrates certain patients may remain infectious for prolonged periods of time and highlights the need for further studies to understand risk factors for prolonged infectious SARS-CoV-2 shedding.Victoria A. Avanzato, M. Jeremiah Matson, Stephanie N. Seifert, Rhys Pryce, Brandi N. Williamson, Sarah L. Anzick, Kent Barbian, Seth D. Judson, Elizabeth R. Fischer, Craig Martens, Thomas A. Bowden, Emmie de Wit, Francis X. Riedo, Vincent J. Munsterhttps://secure.jbs.elsevierhealth.com/action/getSharedSiteSession?redirect=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2820%2931456-2%3Frss%3Dyes&rc=0http://www.cell.com/cell/inpress.rssCellCell RSS feed.Wireless News CampaignNovember 5, 2020
Powered by WPeMatico